Sun Tiemin introduced
Sun Tiemin, male, 1958+00 was born in Jilin in June. He is now a professor of medicinal chemistry (Grade II) at Shenyang Pharmaceutical University, a doctoral supervisor, a member of the Pharmaceutical Engineering Committee of the Education Steering Committee of Chemistry and Chemical Engineering in institutions of higher learning of the Ministry of Education, a member of the editorial board of chinese journal of medicinal chemistry 1 Zhongnan Pharmacy, a national licensed pharmacist and a national medicinal chemistry expert. Head of the experimental teaching center of medicinal chemistry of the National Experimental Teaching Demonstration Center, principal of the national excellent course Medicinal Chemistry, principal of the national bilingual teaching demonstration course Medicinal Chemistry, principal of the national excellent courses Introduction to Pharmacy and Chemical Pharmaceutical Technology. Person in charge of pharmaceutical engineering in national universities; He has been honored as a famous teaching teacher in Liaoning Province, a professional leader (major in pharmaceutical engineering) in ordinary universities in Liaoning Province, and an advanced individual in laboratory construction in Liaoning Province. Won the second prize of national teaching achievement and the second prize of Liaoning teaching achievement; Editor-in-chief, editor-in-chief of more than 20 national planning textbooks, won the second prize of the National Excellent Textbook for ordinary colleges and universities of the Ministry of Education, the first prize of the Eighth China Excellent Textbook for Petroleum and Chemical Industry, and the first prize of the National Excellent Textbook for Medical Colleges and Universities. In recent ten years, he has published 5 papers on educational reform and more than 30 scientific research papers, including more than 20 SCI papers. He presided over 2 provincial education reform projects and 5 scientific research projects, such as the research on the key anti-AIDS drug emtricitabine in the Tenth Five-Year Plan. Apply for patent 10. Research direction: total synthesis or semi-synthesis of natural active products, natural total synthesis and chiral drug synthesis, structural transformation of natural anti-free radical substances, especially anti-tumor and anti-infective substances: chiral drug synthesis, with emphasis on industrial feasible processes. At present, cooperative laboratories are being established with pharmaceutical companies.